RB Clincopathologic Conference (CPC) 3/18/2016 Thomas Shoemaker, MD Ronald Hamilton, MD.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
Practical Management of MS in the Primary Care Office Setting Case Study 2.
Richard P. Halgin Susan Krauss Whitbourne University of Massachusetts at Amherst slides by Travis Langley Henderson State University Abnormal Psychology.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Jeffrey Cummings, MD Mary S. Easton Center for Alzheimer’s Disease Research Deane F. Johnson Center for Neurotherapeutics David Geffen School of Medicine.
HPI A 73-year-old woman is brought to your practice by her husband who is concerned for his wife’s well-being. He explains that for the past few months.
DEMENTIA By: Angela Pabon. What is Dementia? Dementia does not always mean that one has Alzheimer's disease, there are over 80 forms of dementia The definition.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
A 67-year-old male with behavioral and language problems
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Treatment of Parkinson’s Disease Dementia (PDD) Shanil Ebrahim.
Parkinson’s Plus By: Glen Estrosos.
Imaging Degenerative Diseases of the Brain Cathleen Kouvolo.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
2010 MEETING, PHILADELPHIA AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS DSS CASE # 11 J-M BILBAO, B YOUNG and N LIU SUNNYBROOK HOSPITAL UNIVERSITY OF TORONTO.
 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s is the most common form of dementia. This.
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
NYU Medical Grand Rounds Clinical Vignette Megha Shah PGY-2 November 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
D E M E N T I A Q: What other types of dementia are there? Q: What other types of dementia are there? Q: Do they have the same pathophysiology as Alzeimer.
A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Case 1….. A patient delays initiation of movement, displays an uneven trajectory in moving her hand from above her head to touch her nose, and is uneven.
PARKINSON’S DISEASE.
Pathogenesis and pathology of parkinsonism
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Diseases and Disorders of the Nervous System. schizophrenia Characterized by psychotic episodes involving hallucinations & delusions Genetic & environmental.
Tutorial 8 November 8, Motor unit: 1 motor neuron and all the muscle fibres it comes in contact with.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Frontotemporal Lobar Degeneration:
This is an umbrella term, not a disease in its own right. It is a term used for a large group of symptoms that adversely affect the brain and can be caused.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Absence of β-Amyloid Deposits After Immunization in.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
Direct motor pathway Corticospinal pathway.
Alzheimer Disease (Senile Dementia) Characterized by progressive memory loss, is increasingly common in developed countries as populations include more.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Dementia with Lewy Bodies
The ageing brain Volume reduction: begins around 50 with a loss of brain weight of around 2-3% per decade Changes in nerve cell numbers and size - various.
GM Clincopathologic Conference (CPC) 11/20/2015
By: Johanna Miner, Kendra Hobbs and Ainsley MAcDonald
Dementia: from molecules to minds
Parkinson’s Disease Celsey and Chylee.
Parkinson's disease KRZYSZTOF NICPOŃ.
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
Clinicopathologic Conference (CPC) 02/05/16
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
III. Parkinson Disease.
Parkinson’s disease.
Long Term Effects of Concussions
Atypical Parkinsonian Syndromes
Can we find dementia in the skin?
Keith A. Josephs, MD, MST, MSc  Mayo Clinic Proceedings 
Chapter 30 Delirium and Dementia
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Transmissible human proteopathies: an expanding field
CNS.
Neurodegenerative diseases
Mia Yang, MD Please grab a clicker
Introduction to degenerative brain disease
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

RB Clincopathologic Conference (CPC) 3/18/2016 Thomas Shoemaker, MD Ronald Hamilton, MD

History 2008: I saw RB for her problem with imbalance. As you know, the patient is a 74-year-old woman who indicates that while in Hawaii for winter and spring she suffered a fall without obvious provocation. Since that time, the patient has had a fear of falling. There has been minimal dizziness, but there has been a tendency to fall with veering of gait more so to the left than to the right. The patient notes no hearing loss, tinnitus, or ear fullness aside from her baseline which includes hearing loss on the right. The patient does not complain of double vision, blurred vision, blindness, numbness, clumsiness, confusion, loss of consciousness, nor difficulty with speech or swallowing. – Dx: Fear of falling..

History 2010: Seen for abnormal gait and falls. She has difficulty walking and getting out of a chair, also having problems getting dressed – The patient was started on Sinemet regular 25/100, and she has titrated this up to 1 tablet 3 times a day. She states that she had no benefit from this medication.. – Ddx: Question vascular parkinsonism. There is also a possibility of atypical Parkinson disease. 2011: Worsened after d/c of sinement, placed back on.. ? of LE parkinsonism 2014: Dyskinesias

History Past Medical History dementia Parkinson's HTN hyperlipidemia depression Past Surgical History eye surgery (cataracts/glaucoma) cochlear implant

History Family History mother deceased 77 MI father deceased 57 MI sister polio (childhood, since recovered) Social History resident of The Atria (assisted living facility) past 2 years tobacco never EtOH none +walker married, 3 children (living in HI, NY, TX)

FTD? 5/21/2012: NeuroPsych Battery Testing Within normal limits: Geriatric Depression Scale: 3/15 MMSE: 28/30 Go/No Go HVLT Delayed Recall: 11/12 HVLT Recognition (true positives:11/12)

FTD? 5/21/2012: NeuroPsych Battery Abnormal Testing Peaks and Plateaus: 2 errors Trail Making Trails A (>2 standard deviations (SD) below the norm for age and education level.) Trail Making Trails B (>2 standard deviations (SD) below the norm for age and education level.) Both her trails A and B demonstrate signs of executive dysfunction. Clock Drawing: 5/8 (>2standard deviations (SD) below the norm for age and education level.)

FTD? 5/21/2012: NeuroPsych Battery Summary: She is exhibiting signs that are more consistent with a frontotemporal dementia. Further, she does not have signs of major depression at this time.

Psychic Abilities? 10/26/2012: The patient comes in for her appt today. She is not accompanied by her husband, who had an appt of his own, although he did drive her into the office. She remains quite interested in politics and is worried about an announcement Donald Trump will be making today about President Obama.

Examination Mental Status: (performed only by PM&R, 6/28/2015) – No aphasia or dysarthria. However noted to by hypophonic – Following multi step commands. Concentration intact and fluid. – 3 object identification intact to pen, glasses, stethoscope – recall of 3/3 at 5 minutes though patient admits to normally having difficulty with this test with doctors, particular at the end of the day

Examination There was mild facial masking. Blink frequency was decreased. Voice was mildly hypophonic. Muscle strength was 5/5 bilaterally in upper extremities. She has 4/5 hip flexors/extensors, knee extensors, 3/5 knee flexors. Examination of tone revealed mild to moderately increased in the bilateral upper and lower extremities. Adventitious movements: without dyskinesia. resting tremor - none appreciated action tremor - none appreciated Postural in outstretched and wingbeating positions - none appreciated

Examination Finger taps were decreased in speed and amplitude. Foot taps were decreased amplitude. +palmomental reflex Rapid alternating movements were slowed and without dysmetria. Posture was mildly stooped

Radiology MRI ETC:

Differential Diagnosis Progressive Supranuclear Palsy Vascular Parkinsonism Parkinson’s Disease Fronto-temporal Demetria Alzheimer’s Disease Parkinson’s Disease Dementia

Predicted Pathology- PSP GROSS: Atrophy of subthalamic nucleus, midbrain tectum and the superior cerebellar peduncle. – Substantia nigra may show loss of pigment corresponding to nigrostriatal dopaminergic degeneration. Microscopic: Neuronal loss, gliosis and neurofibrillary tangles in basal ganglia, diencephalon and brainstem. – Characteristic tau pathology is also found in glia

Predicted Pathology- FTD Predicted Gross pathology: Decreased brain weight with varying degrees of mesial temporal lobe and frontotemporal atrophy with corresponding lateral ventricular enlargement. Predicted Micro pathology: – Pick bodies (argyrophilic intracytoplasmic inclusions) – Neuronal and glial tau deposits

Histopathology Slide A – H&E H&E – Abeta Abeta – Bielschowsky Bielschowsky – P-Tau P-Tau – Alpha synuclein Alpha synuclein Slide B – H&E H&E

Histopathology Slide G – H&E H&E – P-Tau P-Tau – Alpha Synuclein Alpha Synuclein Slide E – H&E H&E – TDP43 TDP43 – P-Tau P-Tau – Alpha Synuclein Alpha Synuclein

Histopathology Slide J – H&E H&E – Alpha Synuclein Alpha Synuclein Slide H – H&E H&E – Alpha Synuclein Alpha Synuclein Slide I – H&E H&E

Diagnostic comment the decedent’s husband, indicates that the cognitive difficulties appeared before the Parkinsonian symptoms. With this history, then, the presence of alpha-synuclein aggregates in the amygdala, hippocampus and frontal lobe are diagnostic of Dementia With Lewy Bodies (DLB). Parkinson’s disease must have extra-pyramidal motor symptoms for over a year prior to the emergence of cognitive difficulties and neuropathologically would show severe loss of neurons in the substantia nigra along with much greater alpha-synuclein aggregation in the rest of the brainstem than seen here. Alpha-synuclein aggregates outside of the brainstem are usually not present until end-stage Parkinson’s disease. Many cases of DLB are accompanied by varying degrees of Alzheimer’s Disease pathology. In this case, neocortical beta-amyloid deposits were not present and there was only mild amyloid angiopathy. A Bielschowsky silver stain confirmed that there were no neocortical neuritic plaques or neurofibrillary tangles. A few neurofibrillary tangles were noted in the mesial temporal lobe structures (primarily hippocampus) but these are very common at this age and without neocortical neuritic plaques, do not indicate Alzheimer’s Disease. Finally, the possibility of a frontotemporal dementia (FTD) was mentioned during clinical evaluations and additional history of head trauma (concussion) was revealed. However, tau immunostains do not show any evidence of a Chronic Traumatic Encephalopathy and no residual injury was seen by gross examination or microscopic evaluation. There is no evidence of a tau-related frontotemporal dementia (e.g., Pick’s disease) and TDP-43 stains are negative, excluding that type of frontotemporal dementia.